Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,231 | 1,131 | 71.5% |
| Consulting Fee | $5,890 | 5 | 19.8% |
| Unspecified | $1,169 | 1 | 3.9% |
| Education | $829.72 | 11 | 2.8% |
| Travel and Lodging | $590.63 | 1 | 2.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $7,847 | 184 | $0 (2024) |
| ABBVIE INC. | $3,884 | 194 | $0 (2024) |
| UCB, Inc. | $2,533 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,977 | 109 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,934 | 65 | $0 (2024) |
| GENZYME CORPORATION | $1,567 | 66 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,483 | 10 | $0 (2018) |
| Lilly USA, LLC | $1,242 | 56 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $758.37 | 42 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $704.64 | 56 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,802 | 172 | ABBVIE INC. ($692.40) |
| 2023 | $3,985 | 185 | Janssen Biotech, Inc. ($709.00) |
| 2022 | $5,631 | 161 | Janssen Biotech, Inc. ($1,714) |
| 2021 | $3,092 | 151 | AbbVie Inc. ($741.80) |
| 2020 | $2,158 | 96 | Novartis Pharmaceuticals Corporation ($541.52) |
| 2019 | $2,062 | 125 | Regeneron Healthcare Solutions, Inc. ($428.97) |
| 2018 | $3,223 | 132 | Actelion Pharmaceuticals US, Inc. ($1,169) |
| 2017 | $5,757 | 127 | Janssen Biotech, Inc. ($4,014) |
All Payment Transactions
1,149 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Immunology | ||||||
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $120.25 | General |
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.76 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.26 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Inflammation & Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $5.56 | General |
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROVE-AC-079A501 | Actelion Pharmaceuticals US, Inc. | $1,169 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,766 | 11,889 | $1.2M | $586,620 |
| 2022 | 38 | 3,783 | 13,553 | $1.3M | $641,619 |
| 2021 | 37 | 4,028 | 14,837 | $1.7M | $871,105 |
| 2020 | 38 | 4,030 | 10,859 | $1.5M | $771,251 |
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 29 | 554 | $215,191 | $115,073 | 53.5% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 35 | 636 | $165,170 | $87,403 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 780 | 1,223 | $164,372 | $73,944 | 45.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 346 | 442 | $73,672 | $33,450 | 45.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 355 | 437 | $65,278 | $27,373 | 41.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 543 | 785 | $77,972 | $26,615 | 34.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 99 | 110 | $49,606 | $24,155 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 212 | $40,380 | $19,407 | 48.1% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 24 | 24 | $35,906 | $18,436 | 51.3% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 28 | 536 | $31,593 | $16,801 | 53.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 39 | 46 | $32,416 | $16,057 | 49.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 28 | 103 | $29,729 | $15,838 | 53.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 429 | 3,005 | $29,984 | $14,882 | 49.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 88 | 108 | $27,067 | $12,728 | 47.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 79 | 93 | $33,837 | $9,056 | 26.8% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 11 | 11 | $15,229 | $8,104 | 53.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 131 | 193 | $14,331 | $7,560 | 52.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $12,051 | $6,446 | 53.5% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 26 | 82 | $10,280 | $5,498 | 53.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 44 | 50 | $19,947 | $5,378 | 27.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 55 | 57 | $10,565 | $5,140 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $9,094 | $4,354 | 47.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $8,755 | $4,018 | 45.9% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 13 | 2,601 | $6,601 | $3,373 | 51.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 31 | 32 | $12,031 | $3,323 | 27.6% |
About Dr. Anthony Porter, MD
Dr. Anthony Porter, MD is a Dermatology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013957133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Porter, MD has received a total of $29,710 in payments from pharmaceutical and medical device companies, with $3,802 received in 2024. These payments were reported across 1,149 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($21,231).
As a Medicare-enrolled provider, Porter has provided services to 15,607 Medicare beneficiaries, totaling 51,138 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Melbourne, FL
- Active Since 06/07/2006
- Last Updated 09/30/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013957133
Products in Payments
- TREMFYA (Drug) $3,006
- DUPIXENT (Biological) $2,844
- SKYRIZI (Biological) $1,741
- VALCHLOR MECHLORETHAMINE (Drug) $1,483
- TALTZ (Drug) $1,060
- COSENTYX (Biological) $1,003
- STELARA (Biological) $913.22
- Cimzia (Drug) $907.67
- RINVOQ (Biological) $790.67
- Humira (Biological) $701.55
- XOLAIR (Biological) $633.29
- HUMIRA (Biological) $467.82
- ILUMYA (Biological) $462.80
- Bimzelx (Biological) $445.17
- SPEVIGO (Drug) $425.27
- ADBRY (Biological) $394.09
- Enbrel (Biological) $384.95
- VTAMA (Drug) $365.39
- DUPIXENT (Drug) $318.28
- CIBINQO (Drug) $269.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Melbourne
Dr. Adam Wiener, D.o, D.O
Dermatology — Payments: $28,330
Anita Saluja, Md, MD
Dermatology — Payments: $16,168
Ms. Megan Cronin, Md, MD
Dermatology — Payments: $6,571
Dr. Alexandra Grammenos, Do, DO
Dermatology — Payments: $3,597
Dr. Vanessa Johnson, M.d, M.D
Dermatology — Payments: $2,044
Larry Bishop, Md, MD
Dermatology — Payments: $302.52